pH-Dependent Antibodies: An Elegant Strategy for Extending Half-Life and Enhancing Target Clearance-Custom Antibody Development Topic-Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

pH-Dependent Antibodies: An Elegant Strategy for Extending Half-Life and Enhancing Target Clearance

In the field of antibody drug development, extending serum half-life and improving target clearance efficiency have always been two core challenges. Conventional IgG antibodies achieve a serum half-life of several weeks through the FcRn-mediated recycling pathway; however, this same mechanism brings a troublesome side effect: for soluble antigens, the antibody can act as an "antigen buffer," prolonging rather than accelerating the antigen's residence in circulation. The emergence of pH-dependent antibodies offers an elegant solution to this dilemma. This article reviews the core mechanisms and engineering strategies underlying the development of pH-dependent antibodies.

Core Mechanisms and Strategies of pH-Dependent Antibodies

Monoclonal antibodies (mAbs) are used as therapeutics for a wide range of diseases because of their ability to bind antigens with high specificity and affinity. The most commonly used antibodies are based on human immunoglobulin G1 (IgG1). Because IgG1 recycling is mediated by a pH-dependent binding interaction between its Fc region and the neonatal Fc receptor (FcRn), the average half-life of human plasma IgG1 is approximately three weeks. Put simply, IgG in the blood is taken up by cells through fluid-phase pinocytosis and subsequently enters endosomal vesicles, where the mildly acidic pH favors FcRn binding. The FcRn–IgG complex is then recycled back to the cell surface, and upon exposure to the near-neutral pH of the extracellular environment, IgG is released from the receptor. FcRn therefore protects IgG from lysosomal degradation in a strictly pH-dependent manner, which explains the exceptionally long half-life of IgG.

However, when IgG binds a soluble antigen with high affinity at neutral pH, the antigen–antibody complex is internalized together with the antibody. In the acidic endosome, the complex remains bound, so the antigen is recycled along with the antibody rather than being delivered to the lysosome for degradation. As a result, the antibody's long half-life is effectively "transferred" to the antigen, paradoxically prolonging target exposure.

Figure 1. Mechanism of action by which FcRn extends antibody half-life.

The pH-dependent antibody strategy: engineering the antigen-binding properties of IgG by introducing pH-sensitive binding characteristics into the antibody variable region, so that the antibody retains high affinity at near-neutral pH (in the bloodstream) but shows reduced affinity when the pH drops (for example, in the acidic endosomal environment). In this way, the antigen can be released in the acidic endosome and degraded by the lysosome, while IgG is recycled in an FcRn-dependent manner and released into the extracellular space, ready to bind new antigen. A single antibody molecule can therefore perform multiple rounds of "antigen sweeping."

Engineering Strategies for pH-Dependent Antibodies

The most widely used approach to engineering acid-switch antibodies is to introduce histidine residues into the variable region. This strategy relies on the fact that histidine has a pKa of approximately 6.0 and can be protonated at pH 6.0 and below, which in the acidic endosome can weaken the interaction between antibody and antigen through electrostatic changes in the antibody paratope. However, such protein-engineering approaches must be carefully optimized so as not to compromise antigen binding at neutral pH or to reduce developability, which could otherwise increase the risk of aggregation and/or immunogenicity. To overcome these challenges, an alternative strategy has recently been reported that enables the discovery of acid-switch IgG antibodies with fully native variable heavy (VH) and variable light (VL) domains. This approach combines phage display technology with large, unscreened human antibody libraries and has proven suitable for discovering IgGs with pH-dependent antigen-binding properties. It can also identify antibody candidates whose variable regions contain no histidine residues at all yet display strong pH responsiveness.

The Affinity Threshold Between Fc and FcRn

An antibody's recycling efficiency also depends on its interaction with FcRn. Multiple studies have shown that pH-dependent antigen binding alone is not sufficient for effective target clearance, and that Fc mutations enhancing FcRn binding are also required. However, using systematic mutational analysis, Borrok et al. revealed a previously underappreciated neutral-pH binding threshold: once the FcRn affinity of an Fc variant at pH 7.4 exceeds a certain critical value, recycling efficiency declines instead, because extremely high-affinity variants bind FcRn tightly at both acidic and neutral pH and are therefore cleared rapidly from the serum. This finding explains why some high-affinity Fc variants perform poorly in preclinical studies, and it defines a rational affinity boundary for Fc engineering.

Summary

The central questions in pH-dependent antibody development are not only "whether pH dependence can be achieved," but also "where the affinity boundary between Fc and FcRn lies"—that is, which combination of pH-dependent parameters should be adopted for a given target, and what FcRn affinity profile should accompany it. As more pH-dependent antibodies enter the clinic, these design principles will be tested and refined against human data.

Tek Biotechnology (Tianjin) Co., Ltd. has established a well-developed pH-dependent antibody development strategy built on a mature yeast display platform and customized FACS screening workflows. The company provides high-quality pH-dependent antibody development services covering a broad range of species (including mouse, rabbit, sheep, goat, bovine and camelid sources) and multiple antibody formats (including Fab, scFv and VHH). In addition, Tek Biotechnology can design tailored pH-dependent antibody development and validation schemes based on customers' downstream testing requirements, helping to overcome the key challenges encountered in their projects.

References

[1] Ghaffari H, et al. A Quantitative Approach to Guiding Target Antigen Selection and Antibody Optimization in Recycling Antibody Discovery. AAPS J. 2025;27(6):152.

[2] Borrok MJ, et al. pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling. J Biol Chem. 2015;290(7):4282-4290.

[3] Tulika T, et al. Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling. Structure. 2024;32(9):1404-1418.e7.

[4] Roopenian, D., Akilesh, S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7, 715–725 (2007).

Previous:None! Next:None!